When Should I Change My Treatments, and Which Drugs Should I Switch To? en español

What about new drugs being researched?

Yes, there are a number of new drugs being researched today, and most hold promise for people who have HIV resistant to currently marketed drugs. You can read more about these experimental anti-HIV drugs on each of our drug class pages (each one is listed in italics below the currently marketed drugs): protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), nucleoside reverse transcriptase inhibitors (NRTIs), entry inhibitors, and integrase inhibitors.

These and other drugs being developed for HIV-positive people who have virus resistant to current options can often be accessed through clinical trials. If you would like to find out if you are eligible for any clinical trials that involve experimental treatments for drug-resistant HIV, there is an interactive web site run by ACRIA, the AIDS Community Research Initiative of America. Another useful service for finding clinical trials is AIDSinfo.nih.gov, a site run by the U.S. National Institutes of Health. They also have "health information specialists" you can talk to at their toll-free number at 1-800-HIV-0440 (1-800-448-0440).

To learn more about new drugs in development for HIV – both for people living with the virus who have not yet taken any therapy or for those who have tried and failed one or more of the current regimens – keep your eyes on AIDSmeds.com for the latest.

Previous

This content is written by the editorial team at AIDSmeds.com.
Please find profiles of this team on our "About Us" page.